1. Cynapsus Therapeutics Appoints Frederick Driscoll to Its Board of Directors

    Cynapsus Therapeutics Appoints Frederick Driscoll to Its Board of Directors

    Cynapsus Therapeutics Inc., a specialty central nervous system pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use, sublingual thin film for the on-demand management of debilitating OFF episodes associated with Parkinson's disease, today announced the appointment of Frederick W. Driscoll ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned